Back to News
Market Impact: 0.1
S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University
Source: PR Newswire
Healthcare & BiotechPrivate Markets & Venture
The inaugural S2S China Symposium announced finalists for its 2026 program. The invitation-only biotechnology startup event is co-hosted by RA Capital Management and Qiming Venture Partners and focuses on connecting science-driven ventures with investors; the excerpt provides no finalist names, funding amounts, or investable company-specific developments.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
- China slows humanoid robot IPO rush as hype outruns reality
- Why is Telix Pharmaceuticals stock sliding today?
- Qatar Says LNG Damage May Take Years to Repair
- Anthropic Mulls New AI Model Amid Investors' Pre-IPO Worries
- Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse